Cartesian Therapeutics, Inc. (RNAC) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $725.16M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.61M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $718.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.58M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $700.71M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.58M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $698.54M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.59M.
Cartesian Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $3.00K | $725.16M | $-4.61M | $-845.79M | $-125.23M | (m) | 3 month · $2.08M | (m) | (m) |
| 2026-03-31 | $0.00 | $3.00K | $718.02M | $-4.58M | $-861.55M | $-148.12M | (m) | 3 month · $2.42M | (m) | (m) |
| 2025-12-31 | $0.00 | $3.00K | $700.71M | $-4.58M | $-822.37M | $-126.24M | (m) | 12 month · $10.52M | (m) | (m) |
| 2025-09-30 | $0.00 | $3.00K | $698.54M | $-4.59M | $-729.80M | $-35.84M | (m) | 3 month · $2.59M | (m) | (m) |
| 2025-06-30 | $0.00 | $3.00K | $695.94M | $-4.58M | $-693.89M | $-2.53M | (m) | 3 month · $3.28M | (m) | (m) |
| 2025-03-31 | $0.00 | $3.00K | $692.58M | $-4.59M | $-709.78M | $-21.79M | (m) | 3 month · $2.51M | (m) | (m) |
| 2024-12-31 | $0.00 | $3.00K | $689.89M | $-4.62M | $-692.07M | $-6.80M | (m) | 12 month · $6.58M | (m) | (m) |
| 2024-09-30 | $0.00 | $2.00K | $687.17M | $-4.61M | $-681.82M | $752.00K | (m) | 3 month · $1.70M | (m) | (m) |
| 2024-06-30 | $0.00 | $2.00K | $560.77M | $-4.59M | $-657.63M | $-101.46M | 3 month · $219.00K | 3 month · $1.59M | (m) | (m) |
| 2024-03-31 | $0.00 | $1.00K | $559.27M | $-4.61M | $-671.47M | $-116.80M | (m) | 3 month · $1.43M | (m) | (m) |
| 2023-12-31 | $0.00 | $1.00K | $179.06M | $-4.60M | $-614.65M | $-440.18M | (m) | 12 month · $20.96M | (m) | (m) |
| 2023-09-30 | $0.00 | $15.00K | $501.92M | $-4.62M | $-436.99M | $60.33M | (m) | 3 month · $2.32M | (m) | (m) |
| 2023-06-30 | $0.00 | $15.00K | $498.02M | $-4.60M | $-427.99M | $65.45M | (m) | 3 month · $2.28M | (m) | (m) |
| 2023-03-31 | $0.00 | $15.00K | $495.73M | $-4.57M | $-416.60M | $74.58M | (m) | 3 month · $2.28M | (m) | (m) |
| 2022-12-31 | $0.00 | $15.00K | $493.31M | $-4.56M | $-394.94M | $93.83M | (m) | 12 month · $10.19M | 12 month · $780.00K | (m) |
| 2022-09-30 | $0.00 | $15.00K | $490.25M | $-4.53M | $-400.83M | $84.91M | (m) | 3 month · $2.60M | (m) | (m) |
| 2022-06-30 | $0.00 | $15.00K | $487.01M | $-4.48M | $-392.94M | $89.61M | (m) | 3 month · $2.56M | (m) | 3 month · $79.00K |
| 2022-03-31 | $0.00 | $12.00K | $461.89M | $-4.60M | $-401.54M | $55.76M | (m) | 3 month · $2.75M | (m) | 3 month · $-79.00K |
| 2021-12-31 | $0.00 | $12.00K | $457.39M | $-4.57M | $-430.32M | $22.52M | (m) | 12 month · $7.72M | (m) | (m) |
| 2021-09-30 | $0.00 | $12.00K | $428.37M | $-4.56M | $-442.56M | $-18.73M | (m) | 3 month · $1.90M | (m) | (m) |
| 2021-06-30 | $0.00 | $12.00K | $424.98M | $-4.56M | $-424.66M | $-4.22M | (m) | 3 month · $1.78M | (m) | (m) |
| 2021-03-31 | $0.00 | $11.00K | $414.21M | $-4.57M | $-429.23M | $-19.57M | (m) | 3 month · $1.78M | (m) | (m) |
| 2020-12-31 | $0.00 | $11.00K | $391.18M | $-4.56M | $-404.63M | $-18.01M | (m) | 12 month · $5.42M | 12 month · $444.00K | 12 month · $-370.00K |
| 2020-09-30 | $0.00 | $11.00K | $386.37M | $-4.58M | $-389.18M | $-7.38M | (m) | 3 month · $1.30M | 3 month · $444.00K | 3 month · $-133.00K |
| 2020-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00K | (m) |
| 2020-06-30 | $0.00 | $10.00K | $370.94M | $-4.55M | $-379.45M | $-13.05M | (m) | 3 month · $1.48M | (m) | (m) |
| 2020-03-31 | $0.00 | $9.00K | $351.18M | $-4.58M | $-355.37M | $-8.76M | (m) | 3 month · $1.41M | (m) | 3 month · $-147.00K |
| 2019-12-31 | $0.00 | $9.00K | $348.66M | $-4.52M | $-335.75M | $8.40M | (m) | 12 month · $5.16M | (m) | (m) |
| 2019-09-30 | $0.00 | $5.00K | $320.48M | $-4.53M | $-320.87M | $-4.92M | (m) | 3 month · $1.30M | (m) | (m) |
| 2019-06-30 | $0.00 | $5.00K | $313.45M | $-4.53M | $-308.87M | $56.00K | (m) | 3 month · $1.25M | (m) | (m) |
| 2019-03-31 | $0.00 | $5.00K | $311.82M | $-4.53M | $-335.80M | $14.82M | (m) | 3 month · $1.18M | (m) | (m) |
| 2018-12-31 | $0.00 | $3.00K | $279.54M | $-4.56M | $-280.40M | $-5.42M | (m) | 12 month · $5.71M | (m) | (m) |
| 2018-09-30 | $0.00 | $3.00K | $277.72M | $-4.52M | $-263.15M | $7.40M | (m) | 3 month · $1.53M | (m) | (m) |
| 2018-06-30 | $0.00 | $3.00K | $275.89M | $-4.48M | $-247.15M | $21.66M | (m) | 3 month · $1.25M | (m) | (m) |
| 2018-03-31 | $0.00 | $3.00K | $274.33M | $-4.40M | $-228.36M | $38.98M | (m) | 3 month · $1.15M | (m) | (m) |
| 2018-01-01 | (m) | $3.00K | $273.13M | $-4.42M | $-215.07M | $53.64M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $3.00K | $273.13M | $-4.42M | $-216.90M | $51.81M | (m) | 12 month · $4.08M | (m) | (m) |
| 2017-09-30 | $0.00 | $2.00K | $266.84M | $-4.41M | $-197.35M | $65.08M | (m) | 9 month · $2.87M | (m) | (m) |
| 2017-06-30 | $0.00 | $1.00K | $265.30M | $-4.41M | $-182.68M | $78.18M | (m) | 6 month · $1.56M | (m) | (m) |
| 2017-03-31 | $0.00 | $1.00K | $212.25M | $-4.38M | $-166.71M | $41.09M | (m) | 3 month · $693.00K | (m) | (m) |
| 2016-12-31 | $0.00 | $1.00K | $211.12M | $-4.52M | $-151.58M | $54.96M | (m) | 12 month · $2.03M | (m) | (m) |
| 2016-09-30 | $0.00 | $1.00K | $207.49M | $-4.55M | $-137.49M | $65.44M | (m) | 9 month · $1.28M | (m) | (m) |
| 2016-06-30 | (m) | $1.00K | $203.12M | $-4.58M | $-129.76M | $68.78M | (m) | 6 month · $649.00K | (m) | (m) |
| 2015-12-31 | $0.00 | $0.00 | $1.00K | $-4.99M | $-111.51M | $-116.49M | (m) | 12 month · $1.12M | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $-87.75M | (m) | 12 month · $1.22M | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $-69.46M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |